Zobrazeno 1 - 10
of 270
pro vyhledávání: '"Axel, Hegele"'
Autor:
Jörg Hänze, Lilly M. Mengen, Marco Mernberger, Dinesh Kumar Tiwari, Thomas Plagge, Andrea Nist, Florentine S. B. Subtil, Ulrike Theiss, Fabian Eberle, Katrin Roth, Matthias Lauth, Rainer Hofmann, Rita Engenhart-Cabillic, Thorsten Stiewe, Axel Hegele
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-16 (2024)
Abstract Background Radiotherapy is essential in the treatment of prostate cancer. An alternative to conventional photon radiotherapy is the application of carbon ions, which provide a superior intratumoral dose distribution and less induced damage t
Externí odkaz:
https://doaj.org/article/fad8adc82b6c4138974260b87cd5e500
Publikováno v:
BMC Urology, Vol 20, Iss 1, Pp 1-6 (2020)
Abstract Background Non-Hodgkin lymphomas, which include Burkitt’s lymphoma, affect the prostate in only 0.1% of cases. They most commonly present as painless lymphadenopathy elsewhere in the body and can cause abdominal or thoracic pain and system
Externí odkaz:
https://doaj.org/article/2935a7306e954f4595631cc6c64df3ee
Publikováno v:
Case Reports in Urology, Vol 2019 (2019)
We report an extremely low birth weight infant with anuria caused by bilateral Candida albicans fungus balls it was treated with a combination of antifungal therapy, irrigation and pyelotomy. This lead to a recovery of renal function, after a follow-
Externí odkaz:
https://doaj.org/article/a067914ba96342e7b87a763440304f51
Publikováno v:
Genes & Immunity.
Exploring the regulation of co-inhibitory (PD-1, PD-L1, CTLA-4) and co-stimulatory (CD28) genes by chemotherapeutic drugs is important for combined immune checkpoint blockade (ICB) therapy. ICB interferes with T-cell receptor and major histocompatibi
Publikováno v:
Cancer Diagn Progn
Background/Aim: Cervical cancer is the most common gynecological indication for pelvic exenteration (PE). It is an ultima ratio approach to cure advanced or recurring tumors. This study aimed to evaluate data from a Single Center Institution in order
Autor:
Corinna U. Keber, Marcus Derigs, Carolin Schultz, Moritz Wegner, Susanne Lingelbach, Viktoria Wischmann, Rainer Hofmann, Carsten Denkert, Axel Hegele, Jörg Hänze
Publikováno v:
Cancer Immunology, Immunotherapy. 71:2381-2389
Immune checkpoint blockade therapy is a treatment option of various metastatic cancer diseases including renal cell carcinoma (RCC). Approved antibody drugs target the co-inhibitory signaling of Programmed Cell Death Ligand-1 (PD-L1) and its receptor
Chemotherapy of Locally Advanced or Metastatic Urothelial Cell Carcinoma: Monocentric Real-Life Data
Publikováno v:
Cancer Management and Research. 12:5077-5084
Background/Aim Up to 30% of all patients will present with an advanced or a metastatic stage (mUCC) at the moment of the initial diagnosis of urothelial cell carcinoma of the bladder (UCC). We investigated the numbers, the efficacy and toxicity of di
Autor:
Gabriel A. Bonaterra, Alexander Schleper, Maximilian Skowronek, Lucia S. Kilian, Theresa Rink, Hans Schwarzbach, Hendrik Heers, Jörg Hänze, Peter Rexin, Annette Ramaswamy, Carsten Denkert, Beate Wilhelm, Axel Hegele, Rainer Hofmann, Eberhard Weihe, Ralf Kinscherf
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4591
Although growth differentiation factor-15 (GDF-15) is highly expressed in PCa, its role in the development and progression of PCa is unclear. The present study aims to determine the density of GDF-15+ cells and immune cells (M1-/M2 macrophages [MΦ],
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac8e6306923aaecb59e1bbfb1e85f1ac
Autor:
Jacques Medioni, Anders Ullén, Laura Doni, Syed A. Hussain, Rodolfo Passalacqua, Daniel Castellano, Aristotelis Bamias, Axel Hegele, Flora Zagouri, Kimon Tzannis
Publikováno v:
Critical Reviews in Oncology/Hematology. 140:80-87
Background. Vinflunine (VFL) is approved in Europe as second-line treatment of metastatic urothelial cancer after failure of platinum-containing therapy. We performed a systematic review and meta-analysis of real-world data (RWD) to assess utilizatio
Publikováno v:
Der Urologe. 58:424-427
Ein gesunder 41-jahriger Mann stellte sich in unserer Klinik mit neu aufgetretenen Schmerzen im Unterbauch und intermittierenden Flankenschmerzen vor. Es zeigte sich ein Tumor des kleinen Beckens unklarer Dignitat. Die Histologie erbrachte den Nachwe